Clinical trial
To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus…
NCT00442052 · POZEN, Industry · Completed
Key facts
| NCT number | NCT00442052 |
|---|---|
| Title | To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin |
| Official title | An Open-Label, Investigator-Blinded, Randomized, Parellel Group Study to Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA 325 Versus Enteric-Coated Aspirin. |
| Lead sponsor | POZEN, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | aspirin, omeprazole |
| Enrollment | 80 |
| Start date | Nov 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Mar 1, 2007 |
| Last update posted | Mar 1, 2007 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: